Depressive Disorder, Major: all 2,805 studies

Page 12 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.

• Treatment of Schizoaffective Disorder Using MifepristoneTerminatedNCT00725270Phase 2/3Results posted
• Cysteamine Therapy for Major Depressive DisorderTerminatedNCT00715559Not applicableResults posted
• Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT00707980Phase 3Results posted
• Study of Brain Response to Emotional Pictures Using a Magnetic Resonance Imaging (fMRI) While on EscitalopramCompletedNCT00707863Phase 4Results posted
• Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)CompletedNCT00705003Phase 2Results posted
• Switching to Duloxetine in Patients With DepressionCompletedNCT00696774Phase 4Results posted
• Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older AdultsCompletedNCT00696293Phase 4Results posted
• Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in AdultsCompletedNCT00694304Phase 3Results posted
• A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant TherapyCompletedNCT00683852Phase 3Results posted
• Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)CompletedNCT00683592Phase 3Results posted
• Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive DisorderCompletedNCT00672958Phase 3Results posted
• Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive DisorderCompletedNCT00672620Phase 3Results posted
• Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic SyndromeCompletedNCT00671515Phase 2Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive DisorderCompletedNCT00669110Phase 2Results posted
• Escitalopram in Adult Patients With Major Depressive DisorderCompletedNCT00668525Phase 3Results posted
• A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)CompletedNCT00644358Phase 3Results posted
• Time to Remission of Depressive Symptoms With Combined SSRI and RamelteonTerminatedNCT00642694Phase 3Results posted
• A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic FeaturesTerminatedNCT00637494Phase 3Results posted
• Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive DisorderCompletedNCT00635219Phase 3Results posted
• Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIsCompletedNCT00633399Phase 2Results posted
• Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive DisorderCompletedNCT00621946Phase 4Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive DisorderCompletedNCT00619619Phase 2Results posted
• Deep Brain Stimulation for Major Depressive DisorderTerminatedNCT00617162Not applicableResults posted
• Treatment of Mood and Marriage Study (TOMMS)CompletedNCT00612807Phase 1/2Results posted
• Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)CompletedNCT00610649Phase 2Results posted
• Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory DepressionCompletedNCT00608543Phase 4Results posted
• Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With DepressionCompletedNCT00602290Phase 4Results posted
• Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive EpisodesCompletedNCT00596817Phase 3Results posted
• Project to Improve Symptoms and Mood in People With Spinal Cord InjuryCompletedNCT00592384Phase 4Results posted
• Combining Medications to Enhance Depression OutcomesCompletedNCT00590863Phase 4Results posted
• Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical FeaturesTerminatedNCT00585585Phase 2Results posted
• The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed PatientsCompletedNCT00581009Phase 1/2Results posted
• Sequential Use of Fluoxetine for Smokers With Elevated Depressive SymptomsCompletedNCT00578669Phase 3Results posted
• Low Field Magnetic Stimulation in Mood Disorders Using the LFMS DeviceCompletedNCT00578383Not applicableResults posted
• A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive DisorderCompletedNCT00555997Phase 2Results posted
• A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) PatientsCompletedNCT00536471Phase 4Results posted
• Study of Brain Response to Emotional Pictures Using a fMRI While on DuloxetineCompletedNCT00532480Phase 4Results posted
• Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major DepressionCompletedNCT00531947Phase 4Results posted
• Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive DisorderCompletedNCT00529789Phase 2Results posted
• A Pilot Study of TMS Effects on Pain and Depression in Patients With FibromyalgiaCompletedNCT00523302Not applicableResults posted
• Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major DepressionCompletedNCT00521352Phase 2Results posted
• Does Dual Therapy Hasten Antidepressant Response?CompletedNCT00519428Phase 4Results posted
• Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and DepressionCompletedNCT00518986Phase 4Results posted
• Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive DisorderCompletedNCT00511810Phase 2/3Results posted
• Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing HomeCompletedNCT00505518Not applicableResults posted
• An Expert System to Reduce Depression in Primary CareCompletedNCT00497874Phase 2Results posted
• Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed PatientsCompletedNCT00474708Phase 4Results posted
• Antidepressant Effects of NR2B in Major DepressionCompletedNCT00472576Phase 1Results posted
• Brain GABA Levels and Treatment Response in Major Depressive DisorderCompletedNCT00464711Phase 4Results posted
• A Study of Infliximab for Treatment Resistant Major DepressionCompletedNCT00463580Phase 4Results posted
• Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and AlcoholismCompletedNCT00452543Phase 4Results posted
• Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDDCompletedNCT00445679Phase 3Results posted
• Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's DiseaseCompletedNCT00437125Phase 4Results posted
• A Study Evaluating Duloxetine in Patients Hospitalized for Severe DepressionCompletedNCT00422162Phase 4Results posted
• Open-label Ziprasidone Study for Psychosis Treatment in AdolescentsCompletedNCT00421954Phase 3Results posted
• A Study for Participants With Major DepressionCompletedNCT00420004Phase 2Results posted
• Research Study for Major Depressive Disorder: Investigation of Glutamate MedicationsCompletedNCT00419003Phase 4Results posted
• A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly PatientsCompletedNCT00406848Phase 4Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal WomenCompletedNCT00406640Phase 3Results posted
• Dichotic Listening as a Predictor of Medication Response in DepressionCompletedNCT00404755Phase 4Results posted
• Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk ProgramCompletedNCT00401726Phase 4Results posted
• Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive DisorderCompletedNCT00388973Phase 3Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive DisorderCompletedNCT00384033Phase 3Results posted
• A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or DependenceCompletedNCT00377299Not applicableResults posted
• STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol AbuseCompletedNCT00369746Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal WomenCompletedNCT00369343Phase 3Results posted
• Imaging Predictors of Treatment Response in DepressionCompletedNCT00367341Not applicableResults posted
• Deep Brain Stimulation for Treatment Resistant DepressionCompletedNCT00367003Not applicableResults posted
• Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major DepressionCompletedNCT00361374Phase 3Results posted
• Biological Markers of Response to Treatment in Major Depressive DisorderCompletedNCT00361218Phase 3Results posted
• Pilot Study of Duloxetine in Psychological ResilienceCompletedNCT00331799Phase 2Results posted
• Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In JapanCompletedNCT00330616Phase 2Results posted
• Spirituality Teaching Program for Depressed AdultsCompletedNCT00322777Not applicableResults posted
• Treatment-Resistant Depression RegistryCompletedNCT00320372Results posted
• AndroGel in Men With Major Depression and Incomplete Response to Antidepressant TreatmentCompletedNCT00304746Phase 4Results posted
• Dichotic Listening as a Predictor of Medication Response in DepressionCompletedNCT00296725Phase 1/2Results posted
• Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECTCompletedNCT00285818Not applicableResults posted
• Magnetic Resonance Imaging Study of Geriatric DepressionCompletedNCT00245557Not applicableResults posted
• Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major DepressionCompletedNCT00237666Phase 4Results posted
• Abilify as an Adjunctive Treatment for Refractory DepressionCompletedNCT00220636Phase 4Results posted
• Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major DepressionCompletedNCT00186498Not applicableResults posted
• Treatment of Nicotine Dependence and Acute DepressionCompletedNCT00186446Phase 4Results posted
• Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C PatientsCompletedNCT00166296Phase 2Results posted
• Depression, Epinephrine, and Platelet FunctionCompletedNCT00166114Phase 4Results posted
• Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression OutcomeCompletedNCT00149825Phase 2Results posted
• Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana DependenceCompletedNCT00149643Phase 2Results posted
• The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated DepressionCompletedNCT00125957Phase 3Results posted
• The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive DisorderCompletedNCT00107120Phase 3Results posted
• Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive DisorderCompletedNCT00105989Phase 3Results posted
• A Study of Aripiprazole in Patients With Major Depressive DisorderCompletedNCT00105196Phase 3Results posted
• Lexapro and Pramipexole and to Treat Major DepressionCompletedNCT00086307Phase 2Results posted
• Rapid Antidepressant Effects of Yohimbine in Major DepressionCompletedNCT00078715Phase 2Results posted
• Study of Pharmacotherapy of Psychotic DepressionCompletedNCT00056472Phase 3Results posted
• REM Sleep Disruption and Its Potential Uses in Depression ManagementCompletedNCT07891806Not applicable
• Temporal Interference Stimulation in Major Depressive Disorder: A Pilot Feasibility StudyCompletedNCT07888387Not applicable
• Feasibility and Preliminary Outcomes of Compassion-Focused Group Therapy for Depression and AnxietyCompletedNCT07876453Not applicable
• Digital Single-Session Cognitive Behavioural Therapy in Healthy AdultsCompletedNCT07873905Not applicable
• iTBS Versus Standard 10 Hz rTMS for Treatment-Resistant Depression (TRD)Active, not recruitingNCT07852065Not applicable
• Comparison of Efficacy of Minocyclin and Celecoxib as Adjunctive Treatment in Treatment Resistant Cases of Major Depressive DisorderCompletedNCT07804979Not applicable
• Activating Voice Journaling for Mental Health With Voice BiomarkersCompletedNCT07789808

← Depressive Disorder, Major overview